The weekly litigation news digest is live. Subscribe now

IP Verse

Use Of Cannabidiol In The Treatment Of Tuberous Sclerosis Complex - EP3641819

The patent EP3641819 was granted to GW Research on Oct 11, 2023. The application was filed on Jun 21, 2018 under application number EP18737374A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3641819

GW RESEARCH
Application Number
EP18737374A
Filing Date
Jun 21, 2018
Status
Granted And Under Opposition
Sep 8, 2023
Publication Date
Oct 11, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
KRAUS & LEDERER PARTGMBBJul 9, 2024KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONUS2016367496
INTERNATIONAL-SEARCH-REPORTCN104490873
INTERNATIONAL-SEARCH-REPORTWO2013168131
INTERNATIONAL-SEARCH-REPORTWO2016191651
INTERNATIONAL-SEARCH-REPORTWO2017204986
INTERNATIONAL-SEARCH-REPORTWO2018002637
INTERNATIONAL-SEARCH-REPORTWO2018002665
OPPOSITIONUS2016166515
OPPOSITIONWO2016191651

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents